This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board Meeting of November 2, 2026 to consider Q2 FY26 results
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.3 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
S H Kelkar has informed BSE and NSE that its Board of Directors will meet on November 02, 2026 to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. The results will be subject to a limited review by the Statutory Auditors. The trading window for insiders remains closed until November 04, 2026.
Routine procedural filing; no immediate impact on shareholders. Watch for the actual results on November 02.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹636.2 Cr | ₹553.9 Cr | +14.9% |
| Operating profit | ₹23.78 Cr | ₹11.38 Cr | +109.0% |
| Profit after tax | ₹14.56 Cr | ₹9.17 Cr | +58.8% |
| EBITDA margin | 12.4% | 9.6% | +2.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.